Taken together, our study revealed that the overexpression of miR-141 augments anoikis resistance in ovarian cancer cells by targeting and repressing the expression of KLF12, which, in turn, competes for binding sites in the survivin promoter with Sp1. This evidence concerns the gene SP1 and ovarian cancer.